#Covid-19 Vaccines

RDIF and Dr. Reddy’s to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India

Moscow, Russia/Hyderabad, India, September 16, 2020 (GPN) – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), a global pharmaceutical company headquartered out of India, have agreed to cooperate…


In India COVID-19 Vaccine ‘COVAXIN’ Phase 2 Trials underway, USA trial 3 to be completed before November whereas WHO say Vaccine will be made possible only by Mid 2021; Russia Claims their ‘Sputnik V’ Vaccine is Authorised for Use amid Phase 3 Trials

NATIONAL, 6 SEPTEMBER, 2020 (GPN) : In USA some of the Top vaccine developers, including Pfizer Inc, Johnson & Johnson and Moderna Inc, plan to issue a public pledge not to seek government approval until their…


Adar Poonawalla in Interview with GPN: “It Will Be At Least 2 to 2 And-a-Half Years Before Everyone in India Can Get the (COVID Oxford) Vaccine.”

MUMBAI, 12th AUGUST, 2020 (GPN): The success of the Covid-19 Oxford vaccine trial has been making global headlines. Indian billionaire Adar Poonawalla, CEO of Serum Institute of India (SI), the largest vaccine manufacturer in the world,…